Effect of a Photolyase-Based Medical Device on Actinic Keratosis in Phototypes III–IV Patients: Real-Life Clinical Setting
Eryfotona provided effective and safe photoprotection and treatment of actinic keratosis on the face and scalp in patients with phototypes III and IV in the real-life clinical setting, showing promising effects on higher-grade lesions.
Authors
- Sara Cataño (ORCID: https://orcid.org/0000-0001-5183-6973)
- Susana Mejia‐Mesa (ORCID: https://orcid.org/0000-0003-1616-5750)
- Sebastián Ramiro Gil-Quiñones (ORCID: https://orcid.org/0000-0002-5974-1431)
- Fernando Bulla Alcalá (ORCID: https://orcid.org/0000-0001-6013-8608)
- Susana Sierra (ORCID: https://orcid.org/0000-0002-2334-8785)
Institutions
- Universidad de La Sabana (CO)
- Universidad El Bosque (CO)
- Pontificia Universidad Javeriana (CO)
- Municipality of Medellín (CO)
- Instituto Nacional de Cancerología (CO)
- Clínica Santa María (CO)
- Universidad Simón Bolívar (CO)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1007/s13555-025-01455-6
- Citations
- 1
- Primary Topic
- Skin Protection and Aging
- Type
- article
- Field-Weighted Citation Impact
- 2.00